glp 1 drug side effects GLP-1 medication for diabetes and weight loss GLP-1 Safety Check - National
Description
The development of GLP-1 receptor agonists Native GLP-1 is unsuitable itself as a therapeutic agent because of its short half-life in vivo
Researchers have also noted that 70% of diabetes patients discontinue GLP-1 receptor agonist treatment within two years, limiting the long-term efficacy of these drugs
Pfeifer KJ, Selzer A, Mendez CE, et al
B., Silveiro, S
Al-Karadsheh, T
Short-Term: Reduction in insulin needs, weight loss, improved post-meal glucose levels, improved glucose levels overall, lower blood pressure and lipid levels
